Participants with PCSK9 LOF variants were less likely to have dyslipidemia when compared with other participants (26.2% vs 54.3%, P < .001) and had lower total cholesterol levels (mean values 161 vs 194 mg/dL, P < .001). The gene discussed is PCSK9; the disease is metabolic syndrome.